Dopamine receptor agonists and sleep disturbances in Parkinson's disease.
Non-ergot dopamine receptor agonists, such as ropinirole, pramipexole, rotigotine and apomorphine, may alleviate some non-motor symptoms in Parkinson's disease (PD) while others may be precipitated. In this review, we discuss how dopamine receptor agonists can both ameliorate and aggravate the sleep problems in PD, a key non-motor symptom of this disease.
Chaudhuri
K Ray
KR
National Parkinson Foundation Centre of Excellence, King's College Hospital, University Hospital Lewisham, London, UK. ray.chaudhuri@uhl.nhs.uk
Logishetty
Kartik
K
D000818:Animals; D018491:Dopamine Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D012893:Sleep Wake Disorders / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D013997:Time Factors
D018491:Dopamine Agonists